降压治疗患者肾功能下降的决定因素:Campania Salute网络研究
该研究纳入Campania Salute网络中4539例高血压患者,平均随访7.5年,10%出现肾小球滤过率(GFR)下降。多因素分析显示,年龄较大、糖尿病、基线GFR较低、随访期间收缩压较高、随访时间较长、左心室质量增加及新发房颤与GFR下降独立相关,而降压药和抗血小板药无影响。
要点
- 降压治疗中,基线GFR较低、左心室质量增加及随访期间血压控制不佳的患者肾功能更易下降。
- 年龄、糖尿病、随访期收缩压、随访时长及新发房颤均与GFR下降独立相关。
- 降压药和抗血小板药物对GFR下降无显著影响。
核心结论
- 在接受降压治疗的高血压患者中,肾功能下降与基线GFR较低、左心室质量增加及随访期间血压控制不理想独立相关。
研究设计与样本
- 研究从Campania Salute网络选取4539例高血压患者(平均年龄53±11岁),随访至少3年且无超过III期慢性肾脏病(CKD),使用CKD-EPI公式计算基线和末次访视的GFR。
主要发现
- 平均随访7.5年,432例(10%)患者出现GFR下降。
- GFR下降患者基线年龄更大、糖尿病比例更高、GFR和射血分数更低、收缩压更高、舒张压更低、左心室质量和相对室壁厚度更高(均P<0.02)。
- 随访期间,GFR下降患者收缩压更高、用药更多、新发房颤更多(均P<0.02)。
- GFR下降概率与年龄较大、糖尿病、基线GFR较低、随访期收缩压较高、随访时间较长、左心室质量增加及新发房颤独立相关,与降压药和抗血小板药无关。
关键数值与推荐
- GFR下降定义为:III期CKD患者GFR较基线下降≥30%,或基线无III期及以上CKD者复合终点为GFR较基线下降≥30%且最终值<60。
临床怎么用
- 对高血压患者应关注基线GFR、左心室质量和随访期间收缩压控制,以识别肾功能下降高风险者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypertension is a leading cause of chronic kidney disease (CKD) and a decrease in glomerular filtration rate (GFR) is associated with a higher prevalence of hypertension and an increased proportion of suboptimal blood pressure (BP) control. METHODS: To investigate characteristics associated with GFR decline, we selected 4539 hypertensive patients from the Campania Salute Network (mean age 53 ± 11 years) with at least 3 years of follow-up (FU) and no more than Stage III CKD. GFR was calculated at baseline and at the last available visit using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation. GFR decline was defined as a ≥30% decrease from initial GFR for patients in Stage III CKD or by a composite ≥30% decrease from baseline and a final value of <60 for those < with Stage III or higher CKD. RESULTS: At a mean FU of 7.5 years, 432 patients (10%) presented with GFR decline. Those patients were older, more likely to be diabetic, with lower GFR and ejection fraction, higher systolic and lower diastolic BP and higher left ventricular (LV) mass and relative wall thickness at baseline; during FU, patients with GFR decline exhibited higher systolic BP, took more drugs and developed more atrial fibrillation (all P < 0.02). The probability of GFR decline was independently associated with older age, prevalent diabetes, baseline lower GFR, higher systolic BP during FU, FU duration, increased LV mass and incident AF with no impact from antihypertensive and antiplatelet medications. CONCLUSIONS: During antihypertensive therapy, kidney function declines in patients with initially lower GFR, increased LV mass and suboptimal BP control during FU.
引用
- Mancusi C, Izzo R, de Simone G, et al. Determinants of decline of renal function in treated hypertensive patients: the Campania Salute Network. Nephrol Dial Transplant. 2018. PMID: 28499044. doi:10.1093/ndt/gfx062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。